Search Reports
Categories
Categories

Global and United States Rare Disease Drug Market Research by Company, Type & Application 2013-2025

Report Code : lhc-hey4038
Published Date : 14 October, 2018 | No of Pages: 100

  • Report Description
  • Table of Contents
  • Related Reports
Summary
Market Segment as follows:
By Type
>1
0.65 1
<0.1
By Application
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
By Company
Novartis AG
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
Sanofi S.A.
Alexion Pharmaceuticals, Inc.
Eli Lilly and Company
Novo Nordisk A/S
AstraZeneca
Eisai Co., Ltd.
Daiichi Sankyo Company Limited
Bayer AG
GlaxoSmithKline
Merck & Co., Inc.
Johnson & Johnson
Biogen, Inc.
Shire
Amgen, Inc.
Deciphera
Atara Biotherapeutics
ProQR
The main contents of the report including:
Section 1:
Product definition, type and application, global and United States market overview;
Section 2:
Global and United States Market competition by company;
Section 3:
Global and United States sales revenue, volume and price by type;
Section 4:
Global and United States sales revenue, volume and price by application;
Section 5:
United States export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Table of Contents
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 >1
1.1.2.2 0.65 1
1.1.2.3 <0.1
1.1.3 Market by Application
1.1.3.1 Hospital Pharmacies
1.1.3.2 Speciality Pharmacies
1.1.3.3 Retail pharmacies
1.1.3.4 Others
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 United States Overview
2 Global and Regional Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 United States
2.2.1 United States Sales by Company
2.2.2 United States Price by Company
3 Global and Regional Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 United States
3.2.1 United States Sales by Type
3.2.2 United States Price by Type
4 Global and Regional Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 United States
4.2.1 United States Sales by Application
4.2.2 United States Price by Application
5 Regional Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 Novartis AG
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Bristol-Myers Squibb Company
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 Celgene Corporation
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 F. Hoffmann-La Roche Ltd.
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Pfizer, Inc.
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Sanofi S.A.
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Alexion Pharmaceuticals, Inc.
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 Eli Lilly and Company
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.9 Novo Nordisk A/S
6.9.1 Company Information
6.9.2 Product Specifications
6.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.10 AstraZeneca
6.10.1 Company Information
6.10.2 Product Specifications
6.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.11 Eisai Co., Ltd.
6.12 Daiichi Sankyo Company Limited
6.13 Bayer AG
6.14 GlaxoSmithKline
6.15 Merck & Co., Inc.
6.16 Johnson & Johnson
6.17 Biogen, Inc.
6.18 Shire
6.19 Amgen, Inc.
6.20 Deciphera
6.21 Atara Biotherapeutics
6.22 ProQR
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion

List of Table
Table Global Market Sales Revenue by Company 2013-2017
Table Global Market Sales Revenue Share by Company 2013-2017
Table Global Market Sales Volume by Company 2013-2017
Table Global Market Sales Volume Share by Company 2013-2017
Table Global Price by Company 2013-2017
Table United States Market Sales Revenue by Company 2013-2017
Table United States Market Sales Revenue Share by Company 2013-2017
Table United States Market Sales Volume by Company 2013-2017
Table United States Market Sales Volume Share by Company 2013-2017
Table United States Price by Company 2013-2017
Table Global Market Sales Revenue by Type 2013-2017
Table Global Market Sales Revenue Share by Type 2013-2017
Table Global Market Sales Volume by Type 2013-2017
Table Global Market Sales Volume Share by Type 2013-2017
Table Global Price by Type 2013-2017
Table United States Market Sales Revenue by Type 2013-2017
Table United States Market Sales Revenue Share by Type 2013-2017
Table United States Market Sales Volume by Type 2013-2017
Table United States Market Sales Volume Share by Type 2013-2017
Table United States Price by Type 2013-2017
Table Global Market Sales Revenue by Application 2013-2017
Table Global Market Sales Revenue Share by Application 2013-2017
Table Global Market Sales Volume by Application 2013-2017
Table Global Market Sales Volume Share by Application 2013-2017
Table Global Price by Application 2013-2017
Table United States Market Sales Revenue by Application 2013-2017
Table United States Market Sales Revenue Share by Application 2013-2017
Table United States Market Sales Volume by Application 2013-2017
Table United States Market Sales Volume Share by Application 2013-2017
Table United States Price by Application 2013-2017
Table United States Export 2013-2017 (Million USD)
Table United States Export 2013-2017 (Volume)
Table United States Import 2013-2017 (Million USD)
Table United States Import 2013-2017 (Volume)
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis AG
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb Company
Table Sales Revenue, Volume, Price, Cost and Margin of Celgene Corporation
Table Sales Revenue, Volume, Price, Cost and Margin of F. Hoffmann-La Roche Ltd.
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer, Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi S.A.
Table Sales Revenue, Volume, Price, Cost and Margin of Alexion Pharmaceuticals, Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly and Company
Table Sales Revenue, Volume, Price, Cost and Margin of Novo Nordisk A/S
Table Sales Revenue, Volume, Price, Cost and Margin of AstraZeneca
Table Sales Revenue, Volume, Price, Cost and Margin of Eisai Co., Ltd.
Table Sales Revenue, Volume, Price, Cost and Margin of Daiichi Sankyo Company Limited
Table Sales Revenue, Volume, Price, Cost and Margin of Bayer AG
Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline
Table Sales Revenue, Volume, Price, Cost and Margin of Merck & Co., Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson
Table Sales Revenue, Volume, Price, Cost and Margin of Biogen, Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Shire
Table Sales Revenue, Volume, Price, Cost and Margin of Amgen, Inc.
Table Sales Revenue, Volume, Price, Cost and Margin of Deciphera
Table Sales Revenue, Volume, Price, Cost and Margin of Atara Biotherapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of ProQR


List of Figure
Figure >1 Market Size and CAGR 2013-2017 (Million USD)
Figure >1 Market Size and CAGR 2013-2017 (Volume)
Figure >1 Market Forecast and CAGR 2018-2025 (Million USD)
Figure >1 Market Forecast and CAGR 2018-2025 (Volume)
Figure 0.65 1 Market Size and CAGR 2013-2017 (Million USD)
Figure 0.65 1 Market Size and CAGR 2013-2017 (Volume)
Figure 0.65 1 Market Forecast and CAGR 2018-2025 (Million USD)
Figure 0.65 1 Market Forecast and CAGR 2018-2025 (Volume)
Figure <0.1 Market Size and CAGR 2013-2017 (Million USD)
Figure <0.1 Market Size and CAGR 2013-2017 (Volume)
Figure <0.1 Market Forecast and CAGR 2018-2025 (Million USD)
Figure <0.1 Market Forecast and CAGR 2018-2025 (Volume)
Figure Hospital Pharmacies Market Size and CAGR 2013-2017 (Million USD)
Figure Hospital Pharmacies Market Size and CAGR 2013-2017 (Volume)
Figure Hospital Pharmacies Market Forecast and CAGR 2018-2025 (Million USD)
Figure Hospital Pharmacies Market Forecast and CAGR 2018-2025 (Volume)
Figure Speciality Pharmacies Market Size and CAGR 2013-2017 (Million USD)
Figure Speciality Pharmacies Market Size and CAGR 2013-2017 (Volume)
Figure Speciality Pharmacies Market Forecast and CAGR 2018-2025 (Million USD)
Figure Speciality Pharmacies Market Forecast and CAGR 2018-2025 (Volume)
Figure Retail pharmacies Market Size and CAGR 2013-2017 (Million USD)
Figure Retail pharmacies Market Size and CAGR 2013-2017 (Volume)
Figure Retail pharmacies Market Forecast and CAGR 2018-2025 (Million USD)
Figure Retail pharmacies Market Forecast and CAGR 2018-2025 (Volume)
Figure Others Market Size and CAGR 2013-2017 (Million USD)
Figure Others Market Size and CAGR 2013-2017 (Volume)
Figure Others Market Forecast and CAGR 2018-2025 (Million USD)
Figure Others Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Rare Disease Drug Market Size and CAGR 2013-2017 (Million USD)
Figure Global Rare Disease Drug Market Size and CAGR 2013-2017 (Volume)
Figure Global Rare Disease Drug Market Forecast and CAGR 2018-2025 (Million USD)
Figure Global Rare Disease Drug Market Forecast and CAGR 2018-2025 (Volume)
Figure United States Rare Disease Drug Market Size and CAGR 2013-2017 (Million USD)
Figure United States Rare Disease Drug Market Size and CAGR 2013-2017 (Volume)
Figure United States Rare Disease Drug Market Forecast and CAGR 2018-2025 (Million USD)
Figure United States Rare Disease Drug Market Forecast and CAGR 2018-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure United States Market Sales Revenue Share by Company in 2017
Figure United States Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure United States Market Sales Revenue Share by Type in 2017
Figure United States Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure United States Market Sales Revenue Share by Application in 2017
Figure United States Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Rare Disease Drug SWOT List
Figure Healthcare & Medical Porter's Five Forces
Please select License
Single User Price:$ 2000
Site License Price:$ 4000
Enterprise Price:$ 4000